Chimera Investment Corporation Announces Date of Second Quarter 2024 Financial Results and Conference Call
Chimera Investment Corporation Announces Date of Second Quarter 2024 Financial Results and Conference Call
Chimera Investment Corporation (NYSE: CIM) (the "Company") announced today that it plans to release its financial results for the second quarter June 30, 2024 on Wednesday, August 7, 2024 prior to 7:00 a.m. EDT. The Company will conduct a conference call and audio webcast to discuss the results on Wednesday, August 7, 2024 at 8:30 a.m. EDT.
Call-in Number: |
||
U.S. Toll Free |
(888) 645-4404 |
|
International |
(862) 298-0702 |
|
Webcast |
||
A replay of the call will be available for two weeks following the conference call. |
||
Conference Call Replay: |
||
U.S. Toll Free |
(877) 660-6853 |
|
International |
(201) 612-7415 |
|
Conference ID |
13747758 |
If you would like to be added to the e-mail distribution list, please visit www.chimerareit.com, click on News & Events, and complete the email notification form.
About Chimera Investment Corporation
Chimera is a publicly traded real estate investment trust, or REIT, that is primarily engaged in the business of investing directly or indirectly through its subsidiaries, on a leveraged basis, in a diversified portfolio of mortgage assets, including residential mortgage loans, Agency RMBS, Non-Agency RMBS, Agency CMBS, and other real estate related securities.
FOR FURTHER INFORMATION
Investor Relations
888-895-6557
www.chimerareit.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240725201007/en/
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks